Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers. The Food and Drug ...
It's been a stellar few months for shares of San Francisco-based biotech company Rigel Pharmaceuticals, which has approved treatments for hematology and oncology — as well as potential new drugs in ...
Nearly one-third of biotech and pharma professionals are thinking about leaving the U.S. to find biopharma jobs, according to ...
Elevator and escalator technicians stole the top spot, bringing in a $106,000 average salary. However, the top 10 percent ...
Preview this article 1 min AI companies need more than office space, the CEO of this real estate developer says. Genentech's ...
ACB says the acquisition of immovable properties and other assets, in India and abroad, may be examined in detail during the ...
The move reflects ongoing restructuring across the biotech sector as companies adapt to tighter funding and the growing ...
Biotech pioneer Genentech to lay off more than 100 workers, including data scientists and executives
After cutting more than 700 jobs locally and across the United States in the past two years, the most storied company in Bay ...
Pharmaceutical company Eli Lilly and Company—or Lilly—announced its plans to build a $6.5 billion manufacturing facility at Generation Park at a news conference Sept. 23.
Members of the 2024 bioprocessing training cohort. Photo courtesy of UNCP PEMBROKE — UNC Pembroke will offer a free, two-week bioprocessing course to prepare individuals for entry-level roles in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results